Slingshot members are tracking this event:

Antares (ATRS) Files NDA with FDA for QuickShot Testosterone Subcutaneous Device

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 21, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords New Drug Application, Fda, Quickshot Testosterone, Subcutaneous, Device